Transition from First Drug Use to Regular Injection among People Who Inject Drugs in Iran

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 55

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AHJK-10-1_008

تاریخ نمایه سازی: 12 مرداد 1403

Abstract:

Background: The study aimed to evaluate the interval between first drug use and regular injection and factors associated with transition from first injection into premature regular injection among people who inject drugs (PWIDs).Methods: In a multicenter cross-sectional study, we recruited ۴۰۰ PWIDs using snowball sampling. Age of first drug use, age of initiation of regular injection, and demographic and behavioral data were collected using face to face interview. Premature transition to regular injection was defined as initiation of regular injection within the five years of first injection. Data were analyzed using bivariate and multivariate logistic regression survey analysis.Findings: The mean age of first drug use and age of initiation of regular injection was ۲۹.۸۷ ± ۶.۵۴ years, respectively. Having history of sexual abuse in childhood [adjusted odds ratio (AOR) = ۳.۱], history of imprisonment (AOR = ۳.۴), use of heroin as the first drug (AOR = ۴.۳), and doing the first injection at friends’ houses (AOR = ۲.۲) or in ruins (AOR = ۲.۲) significantly increased the chance of premature transition to regular injection, while being a female decreased the chance of premature transition to regular injection (AOR = ۰.۴). Compared to curiosity, being friend with a drug user (AOR = ۰.۴), having withdrawal symptoms (AOR = ۰.۲), and low cost of injection (AOR = ۰.۳) at the first occasion of drug injection reduced the chance of premature transition to regular injection.Conclusion: New interventions to prevent injection initiation among drug users are needed and should be integrated in harm reduction programs.

Authors

Masoomeh Koozegar

MSc Student, Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran

Armita Shahesmaeili

Assistant Professor, HIV/STI Surveillance Research Center AND WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Mehdi Noroozi

Assistant Professor, Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Small W, Fast D, Krusi A, Wood E, Kerr T. ...
  • Hassannejad R, Kassaian N, Ataei B, Adibi P. High risky ...
  • Amin-Esmaeili M, Rahimi-Movaghar A, Gholamrezaei M, Razaghi EM. Profile of ...
  • Shahesmaeili A, Haghdoost AA, Soori H. Network location and risk ...
  • Samimi-Rad K, Nasiri TM, Masoudi-Nejad A, Najafi A, Rahimnia R, ...
  • Mumtaz GR, Weiss HA, Abu-Raddad LJ. Hepatitis C virus and ...
  • Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, ...
  • Cheng Y, Sherman SG, Srirat N, Vongchak T, Kawichai S, ...
  • Moeini B, Mousali A, Hazavei M M, Soltanian A, Barati ...
  • Karimi M, Ghaheri H, Assari S, Ahmadi K, Moghani Lankarani ...
  • Assari S, Yarmohmmadi Vesal M, Tavakoli M, Sehat M, Jafari ...
  • Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of ...
  • United Nations Office on Drugs and Crime (UNODC). World drug ...
  • DeBeck K, Wood E, Dong H, Dobrer S, Hayashi K, ...
  • Arreola S, Bluthenthal RN, Wenger L, Chu D, Thing J, ...
  • Miller CL, Strathdee SA, Kerr T, Li K, Wood E. ...
  • Vorobjov S, Des Jarlais DC, Abel-Ollo K, Talu A, Ruutel ...
  • Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. ...
  • van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho ...
  • Mansorian M, Solhi M, Dehdari T, Taghdisi MH, Zamani Alvicheh ...
  • Lawshe CH. A quantitative approach to content validity. Pers Psychol ...
  • Haghdoost AA, Guilanipour M, Saberi Zafarghandi MB, Rastegari A, Hajimaghsoodi ...
  • Shengelia N, Chikovani I, Sulaberidze L. Human immunodeficiency virus prevalence ...
  • Kielland KB. Mortality, morbidity and treatment uptake related to hepatitis ...
  • Rhodes T, Bivol S, Scutelniciuc O, Hunt N, Bernays S, ...
  • Abelson J, Treloar C, Crawford J, Kippax S, van Beek ...
  • Harocopos A, Goldsamt LA, Kobrak P, Jost JJ, Clatts MC. ...
  • Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. ...
  • Best D, Day E, Cantillano V, Gaston RL, Nambamali A, ...
  • Rahimi-Movaghar A, Amin-Esmaeili M, Aaraj E, Hermez J. Assessment of ...
  • Roy E, Arruda N, Bruneau J, Jutras-Aswad D. Epidemiology of ...
  • Al-Tayyib A, Koester S, Langegger S, Raville L. Heroin and ...
  • Bluthenthal R, Chu D, Wenger L, Valente T, Kral A. ...
  • O'Keefe D, Horyniak D, Dietze P. From initiating injecting drug ...
  • Gossop M, Griffiths P, Powis B, Strang J. Severity of ...
  • Yarmohamadi Vasel M, Tavakoli M, Ghanadi F, Farhoudian A, Farhadi ...
  • Roy E, Haley N, Leclerc P, Cedras L, Blais L, ...
  • Guise A, Horyniak D, Melo J, McNeil R, Werb D. ...
  • Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, ...
  • Hadland SE, Werb D, Kerr T, Fu E, Wang H, ...
  • Werb D, Bluthenthal RN, Kolla G, Strike C, Kral AH, ...
  • Malekinejad M, Vazirian M. Transition to injection amongst opioid users ...
  • Dolan K, Moazen B, Noori A, Rahimzadeh S, Farzadfar F, ...
  • نمایش کامل مراجع